Solid lipid nanoparticles and nanoemulsions containing ceramides: Preparation and physicochemical characterization

References

• Bouwstra J, Ponec M. (2006). The skin barrier in healthy and diseased state. Biochimica Biophys Acta 1758:2080–2095.
   PubMed Web of Science ®Google Scholar
• Bouwstra J, Dubbelaar F, Gooris G, Weerheim A, Ponec M. (1999). The role of ceramide composition in the lipid organisation of the skin barrier. Biochimica t Biophys Acta 1419:127–136.
   PubMed Web of Science ®Google Scholar
• Bouwstra J, Gooris G, Dubbelaar F, Weerheim A, IJzerman A, Ponec M. (1998). Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J Lipid Res 39:186–196.
   PubMed Web of Science ®Google Scholar
• Bunjes H, Steiniger F, Richter W. (2007). Visualizing the structure of triglyceride nanoparticles in different crystal modifications. Langmuir 23:4005–4011.
   PubMed Web of Science ®Google Scholar
• Bunjes H, Koch MH. (2005). Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles. J Contr Rel 107:229–243.
   PubMed Web of Science ®Google Scholar
• Choi MJ, Maibach H. (2005). Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol 6:215–223.
   PubMedGoogle Scholar
• Collins-Gold L, Feichtinger N, Warnheim T. (2000). Are lipid emulsions the drug delivery solution? Mod Drug Discov 3:44–46.
   Google Scholar
• Garcia-Fuentes M, Alonso MJ, Torres D. (2005). Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures. J Coll Interf Sci 285:590–598.
   PubMed Web of Science ®Google Scholar
• Hatziantoniou S, Demetzos C. (2006). Qualitative and quantitative one-step analysis of lipids and encapsulated bioactive molecules in liposome preparations by HPTLC/FID (IATROSCAN). J Liposome Res 16:321–330.
   PubMed Web of Science ®Google Scholar
• Hatziantoniou S, Deli G, Nikas Y, Demetzos C, Papaioannou GTh. (2007). Scanning electron microscopy study on nanoemulsions and solid lipid nanoparticles containing high amounts of ceramides. Micron 38:819–823.
   PubMed Web of Science ®Google Scholar
• Holleran WM, Takagi Y, Uchida Y. (2006). Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett 580:5456–5466.
   PubMed Web of Science ®Google Scholar
• Jenning V, Schafer-Korting M, Gohla S. (2000). Vitamin A–loaded solid lipid nanoparticles for topical use: drug release properties. J Contr Rel 66:115–126.
   PubMed Web of Science ®Google Scholar
• Lebwohl M, Herrmann LG. (2005). Impaired skin barrier function in dermatologic disease and repair with moisturization. Cutis 76(6 Suppl):7–12.
   PubMedGoogle Scholar
• Müller R, Mehnert W, Lucks J, Schwarz C, Weyhers A, Weyhers H, Freitas C, Ruhl D. (1995). Solid lipid nanoparticles (SLN)—an alternative colloidal carrier system for controlled drug delivery.Eur J Biopharm 41:62–69.
   Web of Science ®Google Scholar
• Müller R, Mader K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Biopharm 50:161–177.
   PubMed Web of Science ®Google Scholar
• Müller R, Radtke M, Wissing S. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54(Suppl 1):S131–S155.
   PubMedGoogle Scholar
• Osborne DW, Middleton CA, Rogers RL. (1988). Alcohol free nanoemulsions. J Disp Sci Technol. 9:415–423.
   Web of Science ®Google Scholar
• Santos Maia C, Mehnert W, Schäfer-Korting M. (2000). Solid lipid nanoparticles as drug carriers for topical glucocorticoids, Int J Pharm. 196:165–167.
   PubMed Web of Science ®Google Scholar
• Schubert MA, Harms M, Muller-Goymann CC. (2006). Structural investigations on lipid nanoparticles containing high amounts of lecithin. Eur J Pharm Sci. 27(2–3):226–236.
   PubMedGoogle Scholar
• Schubert MA, Muller-Goymann CC. (2005). Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm. 61(1–2):77–86.
   PubMedGoogle Scholar
• Tiwari SB, Amiji MM. (2006). Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J Nanosci Nanotechnol 6(9–10): 3215–3221.
   PubMedGoogle Scholar
• Wissing S, Müller R. (2001). A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles. Int J Cosmet Sci 23:233–243.
   PubMedGoogle Scholar
• Wu H, Ramachandran C, Bielinska A, Kingzett K, Sun R, Weiner N, Roessler B. (2001). Topical transfection using plasmid DNA in a water-in-oil nanoemulsion. Int J Pharm 221:23–34.
   PubMed Web of Science ®Google Scholar
• Yilmaz E, Borchert H. (2006). Effect of lipid-containing, positively charged nanoemulsions on skin hydration, elasticity, and erythema—an in vivo study. Int J Pharm 307:232–238.
   PubMed Web of Science ®Google Scholar
• Zheng W, Kollmeyer J, Symolon H, Momin A, Munter E, Wang E, Kelly S, Allegood J, Liu Y, Peng Q, Ramaraju H, Sullards M, Cabot M, Merrill A. (2006). Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism, and roles in membrane structure, dynamics, signalling, and autophagy. Biochim Biophys Acta Biomembr 1758:1864–1884.
   PubMedGoogle Scholar
• Zulli F, Liechti Ch, Suter F. (2000). Controlled delivery of lipophilic agents to cell cultures for in vitro toxicity and biocompatibility assays. Int J Cosmet Sci 22:265–270.
   PubMedGoogle Scholar